Fonterra's infant formula sales in China are running ahead of its expectations, despite its Chinese joint venture partner running into a rough patch, chairman John Wilson said.
The co-operative's 18.8 per cent-owned partner in China, Beingmate Baby & Child, warned investors this month it was anticipating a first half loss of up to 230 million yuan ($48.7m), compared with a previous forecast for a profit of up to 100m yuan ($21.2m).
The Shenzhen-listed company blamed the downgrade on a fake infant formula scandal, as well as "industry disorder" in the fast-changing Chinese baby milk sector and new regulation including a requirement for brands to be registered with the China Food and Drug Administration.
Wilson told the Herald that the Chinese infant formula market was in a state of "flux" and that it would take six to 18 months to settle down.
"There is a lot of change going on in the Chinese infant formula market at the moment, with government regulation coming in, and that's causing quite a lot destabilisation for most of the infant formula sellers," Wilson said.